Surveillance for and prevention of nonrheumatologic diseases in the patient with a rheumatologic diagnosis.
Many serious adverse events and complications may occur in patients with rheumatologic diseases. Such adverse events and complications may be a direct complication of the disease process or a result of the medications used for the therapy. Primary care physicians are frequently involved in the management of these patients. It is therefore necessary for them to be aware of the currently available recommendations to monitor for adverse events. It is through the understanding of these recommendations and their successful implementation in practice that primary care physicians will contribute to improved patient outcomes.
Department of Family Medicine, University of South Alabama, 1504 Springhill Avenue, Suite 3414, Mobile, AL 36604, USA. emolokhia@usouthal.edu
Ehab A
EA
Molokhia
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000209:etiology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis* / Q000209:etiology; D009140:Musculoskeletal Diseases / Q000150:complications / Q000473:pathology; D009369:Neoplasms / Q000175:diagnosis* / Q000209:etiology; D010024:Osteoporosis / Q000175:diagnosis* / Q000209:etiology; D010820:Physicians; D058007:Physicians, Primary Care; D011159:Population Surveillance; D012216:Rheumatic Diseases / Q000150:complications* / Q000473:pathology; D012219:Rheumatology / Q000379:methods; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D014409:Tumor Necrosis Factor-alpha